Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study

Autor: Yann Pucheu, Stephen Gilbert, Hubert Cochet, Jacques Bonnet, Hervé Douard, Edouard Gerbaud, Michel Montaudon, Alice Horovitz, Warren Chasseriaud, Pierre Coste
Rok vydání: 2013
Předmět:
Male
Time Factors
medicine.medical_treatment
Myocardial Infarction
Infarction
Pilot Projects
Ventricular Function
Left
Heart Rate
Ivabradine
Myocardial infarction
Ejection fraction
Ventricular Remodeling
General Medicine
Middle Aged
Magnetic Resonance Imaging
Imagerie par résonance magnétique nucléaire
medicine.anatomical_structure
Treatment Outcome
Anesthesia
Practice Guidelines as Topic
Cardiology
cardiovascular system
Drug Therapy
Combination
Female
Cardiology and Cardiovascular Medicine
Anti-Arrhythmia Agents
TIMI
Artery
medicine.drug
medicine.medical_specialty
medicine.drug_class
Adrenergic beta-Antagonists
Ischemia
Infarctus du myocarde
Contractility
Percutaneous Coronary Intervention
Angioplasty
Internal medicine
Heart rate
medicine
Humans
cardiovascular diseases
Beta blocker
Aged
business.industry
Myocardium
Benzazepines
medicine.disease
Blood pressure
Heart failure
Left ventricular remodelling
Remodelage ventriculaire gauche
Feasibility Studies
business
Zdroj: Archives of cardiovascular diseases. 107(1)
ISSN: 1875-2128
Popis: Purpose: To evaluate whether ivabradine, when added to current guideline-based therapy, improves Left Ventricular (LV) remodelling in STEMI patients treated with successful PPCI. Methods: This case-control study included sixty-two patients, between June 2011 and July 2012 (the ivabradine group). Ivabradine, at the dose of 5 mg twice daily, was given promptly after PPCI, along with beta-blockers, to obtain HR
Databáze: OpenAIRE
Externí odkaz: